Minimally modified low density lipoprotein (mmLDL) is a well-known risk factor for coronary artery disease. Upregulation of vascular endothelin type B (ET B ) receptors on the vascular smooth muscle cells is predicted to be the molecular mechanism that leads to cardiovascular pathogenesis. The objective of the present study was to examine the hypothesis that mmLDL upregulates ET B receptors in rat coronary artery. The contractile responses to sarafotoxin 6c (ET B receptor agonist) were studied using a sensitive myograph. ETB receptor mRNA and protein expression was determined using real-time PCR and Western blot analysis.
Introduction
Minimally modified low density lipoprotein (mmLDL) comes from low density lipoprotein (LDL). When only the lipid region of LDL is oxidized, mmLDL will be formed. The mmLDL induces monocyte adhesion to endothelial cells and endothelium dysfunction, promotes the formation of oxidized low density lipoprotein (oxLDL) and foam cells, enhances vascular cell migration and proliferation [1] [2] [3] , and participates in atherosclerotic lesion formation; these effects increase the risk of cardiovascular disease, such as coronary heart disease, the leading cause of death worldwide. These biological effects occur through a mechanism involving the stimulation of the receptor-mediated signal transduction pathways [4] . The endothelin system plays important roles in cardiovascular disease pathogenesis. There are two types of endothelin receptors in the vessel, endothelin type A (ET A ) and endothelin type B (ET B ). The ET receptors on the vascular smooth muscle cells are involved in the atherosclerotic process by enhancing contraction and proliferation of the smooth muscle cells [5] [6] [7] . The ET B receptors exhibit plasticity to adapt to the environmental changes. The upregulation of ET-1 and its receptors plays an important role in the pathogenesis of coronary vascular diseases and in the formation of atherosclerotic lesions in animals [8, 9] and in man [7, 10] . The ET B receptor is the principal receptor involved in the progression of coronary vascular diseases [5, 7] . We previously developed an organ culture model that can mimic the upregulation of ETB receptors in cardiovascular disease [11] [12] [13] [14] [15] . Using this model, we demonstrated that the upregulation of ET B receptors induced by organ culture of arteries is via activation of mitogen-activated protein kinase (MAPK) and the downstream nuclear factor-kappaB (NF-κB) intracellular signal transduction pathways [14, 15] . 4 MAPK consists of 3 main pathways, the extracellular signal-regulated protein 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 cascades [16] . The different MAPK pathways represent another group of serine/threonine kinases that act downstream from protein kinase C (PKC) in the smooth muscle cell regulatory cascade [17] . MAPKs play an important role in the intracellular signaling that occurs in response to extracellular stimuli [16] .
Activated MAPK causes phosphorylation and activation of transcription factors in the cytoplasm or nucleus [18] . NF-κB is a pivotal transcription factor down-stream of the MAPK and PKC pathways [19] [20] [21] . PKC participates in signal transduction events in response to specific hormonal, neuronal and growth factor stimuli [22] . Activation of NF-κB is essential for controlling the inducible expression of several genes involved in inflammation and cell proliferation [23] .
Although both mmLDL and ET B receptor upregulation are involved in the pathogenesis of coronary heart disease, their relationships are unknown. The effects of mmLDL on ET B receptor expression in rat coronary artery and the underlying molecular mechanisms remain unclear. The aim of the present study was to determine if mmLDL upregulates ET B receptors in rat coronary artery and if the MAPK-related intracellular signaling pathways are responsible for the upregulation.
Materials and methods

Animal
Sprague-Dawley rats weighing 300-350 g were purchased from the Animal Center of Xi'an Jiaotong University College of Medicine, China. All animals were handled according to the guidelines specified by the Animal Care and Use Committee at Shaanxi Province. The 5 experimental protocols for using the animals were reviewed and approved by the Animal Ethics Committee at Xi'an Jiaotong University.
Chemicals and reagents
The mmLDL and LDL were purchased from the Xiehe Research Institute (Beijing, China).
The sarafotoxin 6c (S6c) (Auspep, Parkville, Australia) was dissolved in 0.9% saline with 0.1% bovine serum albumin. The staurosporine, SB386023, U0126, SP600125, SB203580 and wedelolactone (Sigma, St Louis, MI, USA) were dissolved in DMSO. Analytical grade chemicals and double-distilled water were used throughout the experiments. All drugs were further diluted in buffer solution just before the experiments. The concentrations were expressed as the final molar concentration in the tissue baths.
Preparation of coronary arterial segments and organ culture
The rats were anesthetized with CO 2 . The hearts were quickly removed and chilled in ice-cold bicarbonate buffer solution (for composition, see below). The left anterior descending coronary artery was excised from the myocardium gently [24] , immersed in cold buffer solution, and freed from adhering tissue under a dissection microscope. The vessels were then cut into approximately 1-2 mm long cylindrical segments.
For organ culture, the coronary artery ring segments were placed in 24-well plates, two segments in each well, containing 1 mL of Dulbecco's modified Eagle's medium (DMEM) containing L-glutamine and supplemented with penicillin and streptomycin [25] . As organ culture per se enhances the function and expression of ET B receptors in the coronary artery [26, 27] , we added an organ culture group as a control in the experiments. The culture of the 6 arterial segments was performed in the mmLDL (10 μg/mL) or LDL (10 μg/mL). To examine the mechanism of effects, the specific inhibitors of different intracellular signal transduction pathways were used. The inhibitors and mmLDL were added to DEME simultaneously at the beginning of the organ culture process. In previous experiments, we found that the addition of 1 μl DMSO to the 1 ml DMEM did not modify the upregulation of receptors. The PKC pathway inhibitor was staurosporine (0.1 μM) [28] , and the inhibitors selected to target different kinases leading to ERK1/2 activation were U0126 (10 μM) [13] and SB386023 (10 μM) [29] . U0126 is an inhibitor of the MAP kinase/ERK kinase (MEK) 1/2, the MAPKK of ERK1/2, while SB386023 inhibits raf, the MAPKKK of ERK1/2. The specific JNK and p38 MAPK inhibitors were SP600125 (10 μM) [30] and SB203580 (10 μM) [31] , respectively. To inhibit downstream transcription, the NF-κB-inhibitor wedelolactone (10 μM) [32] was used.
Each inhibitor was added and incubated for 24 h. Thereafter, the artery segments were mounted in myograph baths. For examination by real-time PCR or Western blot, the vessels were frozen in liquid nitrogen and stored at −80 °C until processed.
Analysis of mmLDL modification
Incubation of mmLDL in organ culture induces minimal lipoprotein oxidization. We estimated the oxidation rate of mmLDL with 24 h culture by measuring thiobarbituric acidreactive substances (TBARS). Quantification of TBARS in conditioned media was performed by comparison to a standard curve of malondialdehyde (MDA) equivalents generated by acid catalyzed hydrolysis of 1,1,3,3-tetramethoxypropane in the same conditions as the experimental samples. 7 A myograph was used to record the isometric tension in the isolated coronary arterial segments. The vessel segments were threaded on two 40-μm-diameter stainless steel wires and mounted in a Mulvany-Halpern myograph (Danish Myo Technology A/S, Denmark).
Myograph study
One wire was connected to a force displacement transducer attached to an analog-digital converter unit (ADInstruments, Hastings, U.K.). The other wire was attached to a movable displacement device allowing fine adjustments of the vascular tension by varying the distance between the wires. The experiments were recorded using the software program Chart™ (ADInstruments, U.K.). The arterial segments were immersed in temperature-controlled 
Real-time PCR
Total RNA was extracted from fresh or cultured coronary artery segments using the RNAfast The real-time PCR was carried out with the following profile: 95 °C for 1 min, followed by 40 cycles at 95 °C for 15 s, at 60 °C for 15 s and at 72 °C for 45 s. Dissociation curves were run after the real-time PCR to identify the specific PCR products. Substrate (Pierce Biotechnology) after incubation with a horseradishperoxidase-conjugated secondary antibody (1:5000). β-actin was used as an internal loading control. Densitometric analysis was performed using Image Gauge Ver. 4.0 (Fuji Photo Film Co., Ltd, Japan).
Western blotting
Calculations and statistics
The 
Analysis of mmLDL modification
In the present study, the MDA values of mmLDL before and after 24 h of culture were 10.84±0.79 nM MDA/mg LDL protein and 14.02±1.73 nM MDA/mg LDL protein (p>0.05, n=3).
Effect of mmLDL on upregulation of the ET B receptors
The viability and general contractility of the arteries during organ culture in the presence and In the fresh coronary arteries, S6c induced only negligible contractions. After organ culture for 24 h, S6c induced strong contraction of coronary arteries in a concentration dependent manner, with an E max value of 163%±15% and a pEC 50 value of 8.37±0.10 (Fig. 1A ).
Culture with LDL had a trend to shift the S6c-induced concentration-contraction curve of organ culture toward the left, but there was no significant difference of either E max of 188%±14% or pEC 50 of 8.39±0.08 between LDL group and organ culture control group (p>0.05, n=8) (Fig. 1A) , suggesting that organ culture per se enhances the contraction of the coronary artery induced by S6c. Culture with mmLDL further shifted the S6c-induced concentration-contraction curve of organ culture artery toward the left and significantly
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increased E max (264%±20%, p0.01) and pEC 50 (8.75±0.10, p0.05, n=8) (Fig. 1A) ,
suggesting that mmLDL enhances the contraction of the coronary artery induced by S6c.
ET B receptor mRNA and protein expression was assessed using real-time PCR and Western blot. There were low levels of the ET B receptor mRNA and protein in fresh coronary artery segments. Organ culture alone elevated the ET B receptor mRNA and protein levels compared to the fresh group (p0.01, Fig. 1B-D) . Furthermore, mmLDL significantly enhanced the organ-culture-elevated mRNA and protein levels of ET B receptors (Fig. 1B-D) .
Inhibition of PKC on mmLDL-upregulated ET B receptors
Culture with mmLDL and staurosporine, a specific inhibitor of PKC, markedly inhibited the mmLDL-induced enhancement of the contractile response to S6c, and decreased E max from 264%±20% in the mmLDL group to 204%±19% (p0.01; n=8). Staurosporine also markedly reduced the culture-alone-induced enhancement of the contractile response to S6c, with decreasing E max from 163%±15% in the organ culture group to 110%±10% (p0.01, n=8) ( Fig.   2A ). The percentage decrease staurosporine caused in the mmLDL-induced enhancement of contractile response was 22.7%, and the percentage decrease staurosporine caused in the organ-culture-induced enhancement of contractile response was 32.5%.
The ET B receptor mRNA and protein expression in the coronary arterial smooth muscle cells was examined after culture with staurosporine. The results showed that staurosporine inhibited both the organ culture-and mmLDL-culture-induced elevation of the ET B receptors mRNA ( Fig. 2B ) and protein levels (Fig. 3) . The percentage decrease staurosporine caused in both the mmLDL-enhanced and organculture-enhanced mRNA expression was 27.3%. The percentage decreases staurosporine caused on the mmLDL-enhanced and organ cultureenhanced protein levels were 35.6% and 30.9%, respectively (Fig. 3) .
Inhibition of MAPK on mmLDL-upregulated ET B receptors
Culture with mmLDL and specific inhibitors for ERK1/2 (SB386023 and U0126) totally attenuated the mmLDL-enhanced contractile responses and partly attenuated the organculture-enhanced contractile responses of the coronary artery to S6c. SB386023 and U0126
depressed the E max of the mmLDL-cultured artery from 264%±20% to 106%±10% and 121%±12% (p0.01, n=8) ( Fig. 4A-B) . However, the JNK inhibitor SP600125 and p38
inhibitor SB203580 had no obvious effects on the mmLDL-enhanced contractile responses to S6c ( Fig. 4C-D ).
SB386023 and U0126 markedly reduced the organ-culture-enhanced contractile response to S6c, exhibiting a decreased E max (SB386023 77%±6%, U0126 80%±9%; p0.01; n=8) ( Fig.   4A-B ). SP600125 and SB203580 had no significant inhibitory effects on the organ-cultureenhanced contractile response to S6c (E max : SP600125 235%±20%, SB203580 222%±19%; p>0.05; n=8) ( Fig. 4C-D) .
The ET B receptor mRNA and protein expression in the coronary arteries after culture with MAPK inhibitors was measured using real-time PCR and Western blot analysis. The results showed that the inhibitors for ERK1/2 (SB386023 and U0126) reduced the increases in ET B receptor mRNA expression induced by culture with or without mmLDL, and the decreased degrees were similar in both groups (Fig. 4E) . Also, SB386023 and U0126 totally abolished the mmLDL-increased ET B receptor protein expression and partly attenuated the organculture-increased ET B receptor protein expression (Fig. 3) . In the presence of inhibitors, the reduction of ET receptor-mediated contraction paralleled the reduced expressions of the ET B receptor mRNA and protein. Although both the JNK inhibitor SP600125 and p38 MAPK 13 inhibitor SB203580 slightly reduced the increased expression of ET B receptor mRNA (Fig. 4E) and protein (Fig. 3 ) induced by culture with or without mmLDL groups, there was no significant difference between with or without inhibitors.
Inhibition of NF-κB on mmLDL-upregulated ET B receptors
Wedelolactone, a specific NF-κB pathway inhibitor, shifted the mmLDL-enhanced concentration-contraction curve of the coronary artery induced by S6c toward the right, decreasing the E max to 111%±9% from 264%±20% and the pEC 50 to 8.31±0.09 from 8.75±0.10 in the mmLDL group (p0.01, n=8). Wedelolactone also markedly decreased the culture-alone-enhanced contractile response to S6c, decreasing the E max to 79%±8% compared to that of the culture alone (163%±16%, p0.01, n=8) (Fig. 5A) . Wedelolactone reduced the mmLDL-enhanced and organ-culture-enhanced contractile responses by 58.0%
and 51.5%, respectively.
The mRNA and protein expression levels in the coronary artery showed that wedelolactone almost totally inhibited the mmLDL-increased expression of ET B receptors and partly attenuated the organ-culture-increased expression of the ET B receptors ( Fig. 5B; Fig. 3 ). In the presence of wedelolactone, the reduction of the ET B receptor-mediated contraction paralleled the reduced expression of the ET B receptor mRNA and protein.
Wedelolactone inhibits NF-κB-mediated gene transcription in cells by blocking the phosphorylation and degradation of IκBα. In the present study, we examined the level of IκBα protein.
The results showed that organ culture decreased the IκBα protein level compared to that of the fresh group, and this decrease was further enhanced by addition of mmLDL (Fig.   5C ). In the presence of wedelolactone, the decreased IκBα protein levels were significantly 14 increased in these two groups (p0.05, p0.05, Fig. 5C ), and the percentage decreases were 49.7% in the mmLDL group and 31.9% in the culture alone group.
Discussion
The upregulation of ET B receptors plays an important role in the development of coronary heart disease [8, 9, 11, 33, 34] . Organ culture of mesenteric or cerebral arteries results in ET B receptor upregulation that is similar to that seen in vivo. Organ culture provides a model for studies of the mechanisms involved in enhanced expression of ET B receptors and the underlying molecular mechanisms. The present study showed that organ culture increased the S6c-induced contraction of coronary artery and the expression levels of ET B receptor mRNA and protein, suggesting that organ culture upregulates the ET B receptors of the rat coronary artery, which agrees well with previous studies [26, 27] . The present study also showed that LDL did not significantly increase the contractility of coronary arterial segments, suggesting that LDL may not affect ET B receptor regulation. It should be pointed out that the aim of the present study was to investigate the effects of mmLDL, and the organ culture group was used as a control. We further demonstrated that culture with mmLDL induced a higher contractile response to S6c in coronary arterial segments and a greater increase in ET B receptor mRNA and protein expression in coronary artery than did the organ culture group. These findings show that mmLDL upregulates ET B receptors in the rat coronary artery. The upregulation of ET B receptors has been shown in experimental ischemic stroke, coronary artery infarction and in human atherosclerotic plaque [7, 11] .
It is well known that there is a significant relationship between receptor upregulation and its stimulating factors. PKC takes part in signal transduction events in response to stimuli. In the present study, the PKC inhibitor staurosporine had significant effects on both the organ However, JNK inhibitor SP600125 and p38 inhibitor SB203580 had no obvious effect on organ culture-induced and mmLDL-induced increases of contraction function, mRNA and protein expression of ET B receptors. In some previous studies, the p38 MAPK was not involved in organ culture-induced elevated contractile effects of ET B receptors in rat middle cerebral arteries and porcine coronary arteries [12, 26] , and JNK pathway was not involved in DSP-induced elevated contractile effects and expressions of ET B receptor in rat basilar artery [38] . Therefore, it suggested that JNK and p38 MAPK signaling pathways didn't appear to be involved in the upregulation of ET B receptors induced by mmLDL.
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The NF-κB pathway plays a pivotal role in controlling the inducible expression of genes that contribute to a variety of biological functions, including cell survival, cell proliferation and contraction [39] . the cell cycle, in addition to activating the NF-κB pathway [41] . Organ culture significantly decreased the IκBα protein level compared to that of the fresh group, and this decrease was further enhanced by addition of mmLDL. When wedelolactone was added, the decreased IκBα protein levels were significantly increased in these two groups, and the percentage increase was higher in the mmLDL group than in the organ culture group. The results suggested that organ culture with mmLDL activates the NF-κB pathway by degradation of the IκBα protein.
Our findings are supported by a study in porcine [26] coronary arteries demonstrating that MAPK-related pathways appear to be involved in organ culture upregulation of ET B receptors.
In human ischemic heart disease, there is upregulation of endothelin receptor expression [11] in the coronary arteries. Culture of human internal mammary arteries induces PKC-and MAPK-dependent upregulation of ET B receptors in the smooth muscle cells [42] . The results agree well with our previous studies demonstrating that organ culture of rat mesenteric and cerebral arteries induces upregulation of ET B receptors in the smooth muscle cells, and this upregulation occurs via activation of NF-κB [14] and ERK1/2 MAPK [29, 43] . When LPS is added to the culture, the upregulation of ET B receptors can be further increased in the coronary arteries [44] . Similar results are seen in rat mesenteric arteries when lipid-soluble smoke particles are presented in the process of organ culture. The increased expression of ET B receptors caused by the smoke particles in the vascular smooth muscle cells occurs via activation of the MAPK and NF-κB signaling pathways [15] . Taken together, these data demonstrate that when risk factors (mmLDL, LPS and smoke particles), organ culture, and ischemia induce damage to the arteries, there is activation of intracellular signaling molecules, such as MAPK and NF-κB, and subsequent upregulation of ET B receptors. This phenomenon is seen in the process of cardiovascular disease.
In conclusion, mmLDL upregulates the ET B receptors in coronary arterial smooth muscle cells via activation of the ERK1/2 MAPK and the transcription factor NF-κB. Understanding the underlying molecular mechanisms may provide new options for treating coronary heart disease.
Figure legends
Figure 1
The mmLDL up-regulated ET B receptors in rat coronary artery. After coronary artery rings were cultured with mmLDL (10 μg/mL) or natural LDL (10 μg/mL) for 24 h, the concentration-contraction curves of the artery segments were induced by sarafotoxin 6c.
Organ culture shifted the curves of the fresh artery induced by sarafotoxin 6c toward the left, 
Figure 5
The NF-κB pathway involved in mmLDL-induced upregulation of ET B receptors in the coronary artery. Rat coronary artery segments were cultured with or without mmLDL (10 μg/mL) in the presence of or absence of the NF-κB inhibitor wedelolactone (10 μM) for 24 h. 
